<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38668125</PMID><DateRevised><Year>2024</Year><Month>04</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2035-8385</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>2</Issue><PubDate><Year>2024</Year><Month>Mar</Month><Day>28</Day></PubDate></JournalIssue><Title>Neurology international</Title><ISOAbbreviation>Neurol Int</ISOAbbreviation></Journal><ArticleTitle>Decoding Post-Viral Fatigue: The Basal Ganglia's Complex Role in Long-COVID.</ArticleTitle><Pagination><StartPage>380</StartPage><EndPage>393</EndPage><MedlinePgn>380-393</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.3390/neurolint16020028</ELocationID><Abstract><AbstractText>Long-COVID afflicts millions with relentless fatigue, disrupting daily life. The objective of this narrative review is to synthesize current evidence on the role of the basal ganglia in long-COVID fatigue, discuss potential mechanisms, and highlight promising therapeutic interventions. A comprehensive literature search was conducted using PubMed, Scopus, and Web of Science databases. Mounting evidence from PET, MRI, and functional connectivity data reveals basal ganglia disturbances in long-COVID exhaustion, including inflammation, metabolic disruption, volume changes, and network alterations focused on striatal dopamine circuitry regulating motivation. Theories suggest inflammation-induced signaling disturbances could impede effort/reward valuation, disrupt cortical-subcortical motivational pathways, or diminish excitatory input to arousal centers, attenuating drive initiation. Recent therapeutic pilots targeting basal ganglia abnormalities show provisional efficacy. However, heterogeneous outcomes, inconsistent metrics, and perceived versus objective fatigue discrepancies temper insights. Despite the growing research, gaps remain in understanding the precise pathways linking basal ganglia dysfunction to fatigue and validating treatment efficacy. Further research is needed to advance understanding of the basal ganglia's contribution to long-COVID neurological sequelae and offer hope for improving function across the expanding affected population.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Rudroff</LastName><ForeName>Thorsten</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-2057-7793</Identifier><AffiliationInfo><Affiliation>Department of Health and Human Physiology, University of Iowa, Iowa City, IA 52242, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, University of Iowa Hospitals and Clinics, Iowa City, IA 52242, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>03</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Neurol Int</MedlineTA><NlmUniqueID>101551564</NlmUniqueID><ISSNLinking>2035-8385</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">basal ganglia</Keyword><Keyword MajorTopicYN="N">fatigue</Keyword><Keyword MajorTopicYN="N">long-COVID</Keyword><Keyword MajorTopicYN="N">neuroimaging</Keyword></KeywordList><CoiStatement>The author declares no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>2</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>3</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>3</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>4</Month><Day>26</Day><Hour>13</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>4</Month><Day>26</Day><Hour>13</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>4</Month><Day>26</Day><Hour>9</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>3</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38668125</ArticleId><ArticleId IdType="pmc">PMC11054322</ArticleId><ArticleId IdType="doi">10.3390/neurolint16020028</ArticleId><ArticleId IdType="pii">neurolint16020028</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization  A Clinical Case Definition of Post-COVID-19 Condition by a Delphi Consensus. World Health Organization.  [(accessed on 6 October 2021)];2021  Available online:  https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1.</Citation></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T., Graham M.S., Penfold R.S., Bowyer R.C., Pujol J.C., Klaser K., Antonelli M., Canas L.S., et al. Attributes and predictors of long-COVID. Nat. Med. 2021;27:626&#x2013;631. doi: 10.1038/s41591-021-01292-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01292-y</ArticleId><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236,379 survivors of COVID-19: A retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416&#x2013;427. doi: 10.1016/S2215-0366(21)00084-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(21)00084-5</ArticleId><ArticleId IdType="pmc">PMC8023694</ArticleId><ArticleId IdType="pubmed">33836148</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenforde M.W., Kim S.S., Lindsell C.J., Rose E.B., Shapiro N.I., Files D.C., Gibbs K.W., Erickson H.L., Steingrub J.S., Smithline H.A., et al. Symptom duration and risk factors for delayed return to usual health among outpatients with COVID-19 in a multistate health care systems network&#x2014;United States, March&#x2013;June 2020. Morb. Mortal. Wkly. Rep. 2020;69:993&#x2013;998. doi: 10.15585/mmwr.mm6930e1.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm6930e1</ArticleId><ArticleId IdType="pmc">PMC7392393</ArticleId><ArticleId IdType="pubmed">32730238</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad O., Chan M., Charron C., Chakravarty M.M. Basal Ganglia Dysfunction in Long-COVID: A Cross-Sectional Association Study. Lancet. 2021;6:100134.</Citation></Reference><Reference><Citation>Graham E.L., Clark J.R., Orban Z.S., Lim P.H., Szymanski A.L., Taylor C., DiBiase R.M., Tong Jia D., Balabanov R., Koralnik I.J., et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized COVID-19 &#x201c;long haulers&#x201d;. Ann. Clin. Transl. Neurol. 2021;8:1073&#x2013;1085. doi: 10.1002/acn3.51350.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acn3.51350</ArticleId><ArticleId IdType="pmc">PMC8108421</ArticleId><ArticleId IdType="pubmed">33755344</ArticleId></ArticleIdList></Reference><Reference><Citation>Paprocka J., Machnikowska-Soko&#x142;owska M., Gruszczy&#x144;ska K., Emich-Widera E. Neuroimaging of Basal Ganglia in Neurometabolic Diseases in Children. Brain Sci. 2020;10:849. doi: 10.3390/brainsci10110849.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci10110849</ArticleId><ArticleId IdType="pmc">PMC7697699</ArticleId><ArticleId IdType="pubmed">33198265</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Tan C., Wu J., Chen M., Wang Z., Luo L., Zhou X., Liu X., Huang X., Yuan S., et al. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir. Res. 2021;22:163.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323373</ArticleId><ArticleId IdType="pubmed">32600344</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci R., Cuffaro L., Capozza A., Rosci C., Maiorana N., Groppo E., Reitano M.R., Poletti B., Ticozzi N., Tagliabue L., et al. Brain positron emission tomography (PET) and cognitive abnormalities one year after COVID-19. J. Neurol. 2023;270:1823&#x2013;1834. doi: 10.1007/s00415-022-11543-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00415-022-11543-8</ArticleId><ArticleId IdType="pmc">PMC9873215</ArticleId><ArticleId IdType="pubmed">36692636</ArticleId></ArticleIdList></Reference><Reference><Citation>Douaud G., Lee S., Alfaro-Almagro F., Arthofer C., Wang C., McCarthy P., Lange F., Andersson J., Griffanti L., Smith S.M., et al. Brain imaging before and after COVID-19 in UK Biobank. Nature. 2022;604:697&#x2013;707. doi: 10.1038/s41586-022-04569-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-04569-5</ArticleId><ArticleId IdType="pmc">PMC9046077</ArticleId><ArticleId IdType="pubmed">35255491</ArticleId></ArticleIdList></Reference><Reference><Citation>Hannanu F.F., Cl&#xe9;ment J., Morelot-Panzini C. Brain metabolic impairment in patients with persisting symptoms following SARS-CoV-2 infection: A [18F]FDG-PET study. Eur. J. Nucl. Med. Mol. Imaging. 2022;49:588&#x2013;600.</Citation></Reference><Reference><Citation>Lu Y., Li X., Geng D., Mei N., Wu P.Y., Huang C.C., Jia T., Zhao Y., Wang D., Xiao A., et al. Cerebral micro-structural changes in COVID-19 patients&#x2014;An MRI-based 3-month follow-up study. eClinicalMedicine. 2020;25:100484. doi: 10.1016/j.eclinm.2020.100484.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2020.100484</ArticleId><ArticleId IdType="pmc">PMC7396952</ArticleId><ArticleId IdType="pubmed">32838240</ArticleId></ArticleIdList></Reference><Reference><Citation>Helms J., Kremer S., Merdji H., Clere-Jehl R., Schenck M., Kummerlen C., Collange O., Boulay C., Fafi-Kremer S., Meziani F., et al. Neurologic Features in Severe SARS-CoV-2 Infection. N. Engl. J. Med. 2021;382:2268&#x2013;2270. doi: 10.1056/NEJMc2008597.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMc2008597</ArticleId><ArticleId IdType="pmc">PMC7179967</ArticleId><ArticleId IdType="pubmed">32294339</ArticleId></ArticleIdList></Reference><Reference><Citation>Kandemirli S.G., Dogan L., Sarikaya Z.T., Kara S., Akinci C., Kaya D., Kaya Y., Yildirim D., Tuzuner F., Yildirim M.S., et al. Brain MRI findings in patients in the intensive care unit with COVID-19 infection. Radiology. 2020;297:E232&#x2013;E235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7507997</ArticleId><ArticleId IdType="pubmed">32384020</ArticleId></ArticleIdList></Reference><Reference><Citation>Varatharaj A., Thomas N., Ellul M.A., Davies NW S., Pollak T.A., Tenorio E.L., Sultan M., Easton A., Breen G., Zandi M., et al. Neurological and neuropsychiatric complications of COVID-19 in 153 patients: A UK-wide surveillance study. Lancet Psychiatry. 2020;7:875&#x2013;882. doi: 10.1016/S2215-0366(20)30287-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30287-X</ArticleId><ArticleId IdType="pmc">PMC7316461</ArticleId><ArticleId IdType="pubmed">32593341</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y., Ling Q., Manyande A., Wu D., Xiang B. Brain Imaging Changes in Patients Recovered From COVID-19: A Narrative Review. Front. Neurosci. 2022;16:855868. doi: 10.3389/fnins.2022.855868.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnins.2022.855868</ArticleId><ArticleId IdType="pmc">PMC9072792</ArticleId><ArticleId IdType="pubmed">35527821</ArticleId></ArticleIdList></Reference><Reference><Citation>Luo Y., Gander P., Wang Y., Ponto L., Rudroff T. Long-COVID-19 patients exhibited decreased globus pallidus activity independent of fatigue status&#x2014;An exploratory FDG-PET study; Proceedings of the Society for Neuroscience Annual Meeting; Washington, DC, USA. 11&#x2013;15 November 2023.</Citation></Reference><Reference><Citation>Hampshire A., Trender W., Chamberlain S.R., Jolly A.E., Grant J.E., Patrick F., Mazibuko N., Williams S.C., Barnby J.M., Hellyer P., et al. Cognitive deficits in people who have recovered from COVID-19. eClinicalMedicine. 2021;39:101044. doi: 10.1016/j.eclinm.2021.101044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101044</ArticleId><ArticleId IdType="pmc">PMC8298139</ArticleId><ArticleId IdType="pubmed">34316551</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinhardt J., Radke J., Dittmayer C., Franz J., Thomas C., Mothes R., Laue M., Schneider J., Br&#xfc;nink S., Greuel S., et al. Olfactory transmucosal SARS-CoV-2 invasion as a port of central nervous system entry in individuals with COVID-19. Nat. Neurosci. 2021;24:168&#x2013;175. doi: 10.1038/s41593-020-00758-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-020-00758-5</ArticleId><ArticleId IdType="pubmed">33257876</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Tao M., Shang L., Liu Y., Pan G., Jin Y., Wang L., Hu S., Li J., Zhang M., et al. Assessment of sequelae of COVID-19 nearly 1 year after diagnosis. Front. Med. 2021;8:717194. doi: 10.3389/fmed.2021.717194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.717194</ArticleId><ArticleId IdType="pmc">PMC8649686</ArticleId><ArticleId IdType="pubmed">34888318</ArticleId></ArticleIdList></Reference><Reference><Citation>Hafiz R., Gandhi T.K., Mishra S., Prasad A., Mahajan V., Di X., Natelson B.H., Biswal B.B. Higher limbic and basal ganglia volumes in surviving COVID-negative patients and the relations to fatigue. Neuroimage Rep. 2022;2:100095. doi: 10.1016/j.ynirp.2022.100095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ynirp.2022.100095</ArticleId><ArticleId IdType="pmc">PMC9040524</ArticleId><ArticleId IdType="pubmed">35496469</ArticleId></ArticleIdList></Reference><Reference><Citation>Heine J., Schwichtenberg K., Hartung T.J., Rekers S., Chien C., Boesl F., Rust R., Hohenfeld C., Bungenberg J., Finke C., et al. Structural brain changes in patients with long-COVID fatigue: A prospective observational study. eClinicalMedicine. 2023;58:101874. doi: 10.1016/j.eclinm.2023.101874.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2023.101874</ArticleId><ArticleId IdType="pmc">PMC9969172</ArticleId><ArticleId IdType="pubmed">36873426</ArticleId></ArticleIdList></Reference><Reference><Citation>Deters J.R., Fietsam A.C., Gander P.E., Boles Ponto L.L., Rudroff T. Effect of Long-COVID-19 on Brain Volume and Glucose Metabolism: Influence of Time Since Infection and Fatigue Status. Brain Sci. 2023;13:675. doi: 10.3390/brainsci13040675.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci13040675</ArticleId><ArticleId IdType="pmc">PMC10136956</ArticleId><ArticleId IdType="pubmed">37190640</ArticleId></ArticleIdList></Reference><Reference><Citation>Trifilieff P., Feng B., Urizar E., Winiger V., Ward R.D., Taylor K.M., Martinez D., Moore H., Balsam P.D., Simpson E.H., et al. Increasing dopamine D2 receptor expression in the adult nucleus accumbens enhances motivation. Mol. Psychiatry. 2013;18:1025&#x2013;1033. doi: 10.1038/mp.2013.57.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mp.2013.57</ArticleId><ArticleId IdType="pmc">PMC4030518</ArticleId><ArticleId IdType="pubmed">23711983</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamone J.D., Correa M., Farrar A., Mingote S.M. Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology. 2007;191:461&#x2013;482. doi: 10.1007/s00213-006-0668-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00213-006-0668-9</ArticleId><ArticleId IdType="pubmed">17225164</ArticleId></ArticleIdList></Reference><Reference><Citation>Berke J.D. What does dopamine mean? Nat. Neurosci. 2018;21:787&#x2013;793. doi: 10.1038/s41593-018-0152-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0152-y</ArticleId><ArticleId IdType="pmc">PMC6358212</ArticleId><ArticleId IdType="pubmed">29760524</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamamoto B.K., Zhu W. The effects of methamphetamine on the production of free radicals and oxidative stress. J. Pharmacol. Exp. Ther. 1998;287:107&#x2013;114.</Citation><ArticleIdList><ArticleId IdType="pubmed">9765328</ArticleId></ArticleIdList></Reference><Reference><Citation>Belujon P., Grace A.A. Dopamine System Dysregulation in Major Depressive Disorders. Int. J. Neuropsychopharmacol. 2017;20:1036&#x2013;1046. doi: 10.1093/ijnp/pyx056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ijnp/pyx056</ArticleId><ArticleId IdType="pmc">PMC5716179</ArticleId><ArticleId IdType="pubmed">29106542</ArticleId></ArticleIdList></Reference><Reference><Citation>Yohn S.E., Thompson C., Randall P.A., Lee C.A., M&#xfc;ller C.E., Baqi Y., Correa M., Salamone J.D. The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: Reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion. Psychopharmacology. 2015;232:1313&#x2013;1323. doi: 10.1007/s00213-014-3766-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00213-014-3766-0</ArticleId><ArticleId IdType="pubmed">25323625</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamada K., Kobayashi S., Numata T., Inagaki N. Cytokine alteration of dopamine transporter: A possible causative factor in COVID-19 related fatigue. Med. Hypotheses. 2021;153:110734. Epub ahead of print.</Citation></Reference><Reference><Citation>Hauser T.U., Fiore V.G., Moutoussis M., Dolan R.J. Computational Psychiatry of ADHD: Neural Gain Impairments across Marrian Levels of Analysis. Trends Neurosci. 2016;39:63&#x2013;73. doi: 10.1016/j.tins.2015.12.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tins.2015.12.009</ArticleId><ArticleId IdType="pmc">PMC4746317</ArticleId><ArticleId IdType="pubmed">26787097</ArticleId></ArticleIdList></Reference><Reference><Citation>Haber S.N., Behrens T.E.J. The neural network underlying incentive-based learning: Implications for interpreting circuit disruptions in psychiatric disorders. Neuron. 2014;83:1019&#x2013;1039. doi: 10.1016/j.neuron.2014.08.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.08.031</ArticleId><ArticleId IdType="pmc">PMC4255982</ArticleId><ArticleId IdType="pubmed">25189208</ArticleId></ArticleIdList></Reference><Reference><Citation>Le Heron C., Apps M.A.J., Husain M. The anatomy of apathy: A neurocognitive framework for amotivation in psychopathology. Neurosci. Biobehav. Rev. 2020;118:550&#x2013;578.</Citation></Reference><Reference><Citation>Da Cunha C., Gomez-A A., Blaha C.D. The role of the basal ganglia in motivated behavior. Rev. Neurosci. 2012;23:747&#x2013;767. doi: 10.1515/revneuro-2012-0063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/revneuro-2012-0063</ArticleId><ArticleId IdType="pubmed">23079510</ArticleId></ArticleIdList></Reference><Reference><Citation>Do J.P., Guo D., Ming G.L., Song H. BDNF upregulation rescues NMDA-induced alterations in synaptic plasticity in young and aged hippocampal dentate gyrus granule neurons. Learn. Mem. 2012;19:89&#x2013;96.</Citation></Reference><Reference><Citation>Guo Z.V., Inagaki H.K., Daie K., Druckmann S., Gerfen C.R., Svoboda K. Maintenance of persistent activity in a frontal thalamocortical loop. Nature. 2015;526:181&#x2013;186. doi: 10.1038/nature22324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature22324</ArticleId><ArticleId IdType="pmc">PMC6431254</ArticleId><ArticleId IdType="pubmed">28467817</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu M.H., Vetrivelan R., Fuller P.M., Lu J. Basal ganglia control of sleep-wake behavior and cortical activation. Eur. J. Neurosci. 2010;31:499&#x2013;507. doi: 10.1111/j.1460-9568.2009.07062.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2009.07062.x</ArticleId><ArticleId IdType="pmc">PMC3928571</ArticleId><ArticleId IdType="pubmed">20105243</ArticleId></ArticleIdList></Reference><Reference><Citation>Lazarus M., Chen J.F., Urade Y., Huang Z.-L. Role of the basal ganglia in the control of sleep and wakefulness. Curr. Opin. Neurobiol. 2013;23:780&#x2013;785. doi: 10.1016/j.conb.2013.02.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.conb.2013.02.001</ArticleId><ArticleId IdType="pmc">PMC3683373</ArticleId><ArticleId IdType="pubmed">23465424</ArticleId></ArticleIdList></Reference><Reference><Citation>Paterson R.W., Brown R.L., Benjamin L., Nortley R., Wiethoff S., Bharucha T., Jayaseelan D.L., Kumar G., Raftopoulos R.E., Zambreanu L., et al. The emerging spectrum of COVID-19 neurology: Clinical, radiological and laboratory findings. Brain. 2022;143:3104&#x2013;3120. doi: 10.1093/brain/awaa240.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/brain/awaa240</ArticleId><ArticleId IdType="pmc">PMC7454352</ArticleId><ArticleId IdType="pubmed">32637987</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudroff T., Fietsam A.C., Deters J.R., Bryant A.D., Kamholz J. Long-COVID-19 Fatigue: Potential Contributing Factors. Brain Sci. 2020;10:1012. doi: 10.3390/brainsci10121012.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci10121012</ArticleId><ArticleId IdType="pmc">PMC7766297</ArticleId><ArticleId IdType="pubmed">33352638</ArticleId></ArticleIdList></Reference><Reference><Citation>Havervall S., Rosell A., Phillipson M., Mangsbo S.M., Nilsson P., Hober S., Th&#xe5;lin C. Symptoms and Functional Impairment Assessed 8 Months After Mild COVID-19 Among Health Care Workers. JAMA. 2021;325:2015&#x2013;2016. doi: 10.1001/jama.2021.5612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.5612</ArticleId><ArticleId IdType="pmc">PMC8027932</ArticleId><ArticleId IdType="pubmed">33825846</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R., Lekoubou A., Oh J.S., Ericson J.E., Ssentongo P., et al. Short-term and Long-term Rates of Postacute Sequelae of SARS-CoV-2 Infection: A Systematic Review. JAMA Netw. Open. 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H.E., Assaf G.S., McCorkell L., Wei H., Low R.J., Re&#x2019;em Y., Redfield S., Austin J.P., Akrami A. Characterizing long-COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021;38:101019. doi: 10.1016/j.eclinm.2021.101019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Behnood S.A., Shafran R., Bennett S.D., Zhang A.X.D., O&#x2019;Mahoney L.L., Stephenson T.J., Ladhani S.N., De Stavola B.L., Viner R.M., Swann O.V. Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies. J. Infect. 2022;84:158&#x2013;170. doi: 10.1016/j.jinf.2021.11.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.11.011</ArticleId><ArticleId IdType="pmc">PMC8604800</ArticleId><ArticleId IdType="pubmed">34813820</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 Long-term effects of COVID-19: A systematic review and meta-analysis. Sci. Rep. 2021;11:16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Natelson B.H. Post-infectious fatigue. In: Conti F., Priori A., Grassi C., editors. Brain and Behavior: Plasticity, Compensation and Recovery. Volume 1226 Springer; Cham, Switzerland: 2006.</Citation></Reference><Reference><Citation>Sigfrid L., Drake T.M., Pauley E., Jesudason E.C., Olliaro P., Lim W.S., Gillesen A., Berry C., Lowe D.J., McPeake J., et al. Long-COVID in adults discharged from UK hospitals after COVID-19: A prospective, multicenter cohort study using the ISARIC WHO Clinical Characterization Protocol. Lancet Reg. Health Eur. 2021;8:100186. doi: 10.1016/j.lanepe.2021.100186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Gemelli Against COVID-19 Post-Acute Care Study Group Long-COVID-19 global health strategies: The need for an interdisciplinary approach. Aging Clin. Exp. Res. 2020;32:1613&#x2013;1620. doi: 10.1007/s40520-020-01616-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40520-020-01616-x</ArticleId><ArticleId IdType="pmc">PMC7287410</ArticleId><ArticleId IdType="pubmed">32529595</ArticleId></ArticleIdList></Reference><Reference><Citation>Brosschot J.F., Gerin W., Thayer J.F. The perseverative cognition hypothesis: A review of worry, prolonged stress-related physiological activation, and health. J. Psychosom. Res. 2006;60:113&#x2013;124. doi: 10.1016/j.jpsychores.2005.06.074.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2005.06.074</ArticleId><ArticleId IdType="pubmed">16439263</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas F. Stigma, fatigue and social breakdown: Exploring the impacts of HIV/AIDS on patient and carer well-being in the Caprivi Region, Namibia. Soc. Sci. Med. 2006;63:3174&#x2013;3187. doi: 10.1016/j.socscimed.2006.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2006.08.016</ArticleId><ArticleId IdType="pubmed">16987574</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott A.J., Webb T.L., Rowse G. Does improving sleep lead to better mental health? A protocol for a meta-analytic review of randomized controlled trials. BMJ Open. 2017;7:e016873. doi: 10.1136/bmjopen-2017-016873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2017-016873</ArticleId><ArticleId IdType="pmc">PMC5623526</ArticleId><ArticleId IdType="pubmed">28928187</ArticleId></ArticleIdList></Reference><Reference><Citation>Moturu S.T., Khayal I., Aharony N., Pan J., Pentland A. Using social sensing to understand the links between sleep, mood, and stress; Proceedings of the 2011 Annual International Conference of the IEEE Engineering in Medicine and Biology Society; Boston, MA, USA. 9&#x2013;11 October 2011.</Citation></Reference><Reference><Citation>Fishbain D.A., Cole B., Cutler R.B., Lewis J., Rosomoff H.L., Fosomoff R.S. Is pain fatiguing? A structured evidence-based review. Pain Med. 2003;4:51&#x2013;62. doi: 10.1046/j.1526-4637.2003.03008.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1526-4637.2003.03008.x</ArticleId><ArticleId IdType="pubmed">12873278</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadetoff D., Kosek E. The effects of static muscular contraction on blood pressure, heart rate, pain ratings and pressure pain thresholds in healthy individuals and patients with fibromyalgia. Eur. J. Pain. 2007;11:39&#x2013;47. doi: 10.1016/j.ejpain.2005.12.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpain.2005.12.013</ArticleId><ArticleId IdType="pubmed">16480906</ArticleId></ArticleIdList></Reference><Reference><Citation>Bower J.E. Cancer-related fatigue--mechanisms, risk factors, and treatments. Nat. Rev. Clin. Oncol. 2014;11:597&#x2013;609. doi: 10.1038/nrclinonc.2014.127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrclinonc.2014.127</ArticleId><ArticleId IdType="pmc">PMC4664449</ArticleId><ArticleId IdType="pubmed">25113839</ArticleId></ArticleIdList></Reference><Reference><Citation>Manjaly Z.M., Harrison N.A., Critchley H.D., Do C.T., Stefanics G., Wenderoth N., Lutterotti A., M&#xfc;ller A., Stephan K.E. Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry. 2019;90:642&#x2013;651. doi: 10.1136/jnnp-2018-320050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2018-320050</ArticleId><ArticleId IdType="pmc">PMC6581095</ArticleId><ArticleId IdType="pubmed">30683707</ArticleId></ArticleIdList></Reference><Reference><Citation>Skrzypczak-Wiercioch A., Sa&#x142;at K. Lipopolysaccharide-Induced Model of Neuroinflammation: Mechanisms of Action, Research Application and Future Directions for Its Use. Molecules. 2022;27:5481. doi: 10.3390/molecules27175481.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules27175481</ArticleId><ArticleId IdType="pmc">PMC9457753</ArticleId><ArticleId IdType="pubmed">36080253</ArticleId></ArticleIdList></Reference><Reference><Citation>Ledford H. Long COVID trial provides tentative hope for treatment. Nature. 2024;601:356&#x2013;357.</Citation></Reference><Reference><Citation>Sanghavi D., Bansal P., Kaur I.P., Mughal M.S., Keshavamurthy C., Cusick A., Schram J., Yarrarapu S.N.S., Giri A.R., Kaur N., et al. Impact of colchicine on mortality and morbidity in COVID-19: A systematic review. Ann. Med. 2022;54:775&#x2013;789. doi: 10.1080/07853890.2021.1993327.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2021.1993327</ArticleId><ArticleId IdType="pmc">PMC8920395</ArticleId><ArticleId IdType="pubmed">35258357</ArticleId></ArticleIdList></Reference><Reference><Citation>Saucier J., Comeau D., Robichaud G.A., Chamard-Witkowski L. Reactive gliosis and neuroinflammation: Prime suspects in the pathophysiology of post-acute neuroCOVID-19 syndrome. Front. Neurol. 2023;14:1221266. doi: 10.3389/fneur.2023.1221266.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fneur.2023.1221266</ArticleId><ArticleId IdType="pmc">PMC10492094</ArticleId><ArticleId IdType="pubmed">37693763</ArticleId></ArticleIdList></Reference><Reference><Citation>Salamone J.D., Correa M., Farrar A.M., Nunes E.J., Pardo M. Dopamine, behavioral economics, and effort. Front. Behav. Neurosci. 2009;3:13. doi: 10.3389/neuro.08.013.2009.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/neuro.08.013.2009</ArticleId><ArticleId IdType="pmc">PMC2759361</ArticleId><ArticleId IdType="pubmed">19826615</ArticleId></ArticleIdList></Reference><Reference><Citation>Treadway M.T., Bossaller N.A., Shelton R.C., Zald D.H. Effort-based decision-making in major depressive disorder: A translational model of motivational anhedonia. J. Abnorm. Psychol. 2012;121:553&#x2013;558. doi: 10.1037/a0028813.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/a0028813</ArticleId><ArticleId IdType="pmc">PMC3730492</ArticleId><ArticleId IdType="pubmed">22775583</ArticleId></ArticleIdList></Reference><Reference><Citation>Downs B.W., Blum K., Bagchi D., Kushner S., Bagchi M., Galvin J.M., Lewis M., Siwicki D., Brewer R., Boyett B., et al. Molecular neurobiological and systemic health benefits of achieving dopamine homeostasis in the face of a catastrophic pandemic (COVID- 19): A mechanistic exploration. J. Syst. Integr. Neurosci. 2020;7 doi: 10.15761/JSIN.1000228.</Citation><ArticleIdList><ArticleId IdType="doi">10.15761/JSIN.1000228</ArticleId><ArticleId IdType="pmc">PMC7489293</ArticleId><ArticleId IdType="pubmed">32934824</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J.X., Zhang J.J. Case Report of Improvement in Long-COVID Symptoms in an Air Force Medic Treated With Transcranial Magnetic Stimulation Using Electro-Magnetic Brain Pulse Technique. Mil. Med. 2023;188:e3711&#x2013;e3715. doi: 10.1093/milmed/usad182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/milmed/usad182</ArticleId><ArticleId IdType="pubmed">37267198</ArticleId></ArticleIdList></Reference><Reference><Citation>Linnhoff S., Koehler L., Haghikia A., Zaehle T. The therapeutic potential of non-invasive brain stimulation for the treatment of Long-COVID-related cognitive fatigue. Front. Immunol. 2023;13:935614. doi: 10.3389/fimmu.2022.935614.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2022.935614</ArticleId><ArticleId IdType="pmc">PMC9869163</ArticleId><ArticleId IdType="pubmed">36700201</ArticleId></ArticleIdList></Reference><Reference><Citation>Noda Y., Sato A., Shichi M., Sato A., Fujii K., Iwasa M., Nagano Y., Kitahata R., Osawa R. Real world research on transcranial magnetic stimulation treatment strategies for neuropsychiatric symptoms with long-COVID in Japan. Asian J. Psychiatr. 2023;81:103438. doi: 10.1016/j.ajp.2022.103438.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajp.2022.103438</ArticleId><ArticleId IdType="pmc">PMC9795803</ArticleId><ArticleId IdType="pubmed">36610206</ArticleId></ArticleIdList></Reference><Reference><Citation>Roet M., Boonstra J., Sahin E., Mulders A.E.P., Leentjens A.F.G., Jahanshahi A. Deep Brain Stimulation for Treatment-Resistant Depression: Towards a More Personalized Treatment Approach. J. Clin. Med. 2020;9:2729. doi: 10.3390/jcm9092729.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm9092729</ArticleId><ArticleId IdType="pmc">PMC7565181</ArticleId><ArticleId IdType="pubmed">32846987</ArticleId></ArticleIdList></Reference><Reference><Citation>Chase A. Therapeutic neuromodulation for post-viral fatigue syndromes. Brain Stimul. 2023;16:25&#x2013;31.</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudroff T. The challenges of long-COVID-19 fatigue research. Front. Psychol. 2023;14:1120928. doi: 10.3389/fpsyg.2023.1120928.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyg.2023.1120928</ArticleId><ArticleId IdType="pmc">PMC10083308</ArticleId><ArticleId IdType="pubmed">37051605</ArticleId></ArticleIdList></Reference><Reference><Citation>Fietsam A.C., Bryant A.D., Rudroff T. Fatigue and perceived fatigability, not objective fatigability, are prevalent in people with long-COVID-19. Exp. Brain Res. 2023;241:211&#x2013;219. doi: 10.1007/s00221-022-06518-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00221-022-06518-0</ArticleId><ArticleId IdType="pmc">PMC9735153</ArticleId><ArticleId IdType="pubmed">36462035</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudroff T. Revealing the Complexity of Fatigue: Review of Persistent Challenges and Promises of Artificial Intelligence. Brain Sciences. Brain Sci. 2024;14:186. doi: 10.3390/brainsci14020186.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci14020186</ArticleId><ArticleId IdType="pmc">PMC10886506</ArticleId><ArticleId IdType="pubmed">38391760</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>